Dr. John Malolepszy, MD

  • Braintree, MA
  • Internist
NPI1508993163PAC ID6800708058
Medicare services, 2024
4,076
Medicare patients, 2024
424
Part D claims, 2024
6,789
Hospital affiliations
6
Industry payments
$652
Practice address
111 Grossman Dr, Braintree, MA 02184
Practice phone
Call (617) 421-1000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Harvard Vanguard Medical Associates

Braintree, Massachusetts

See all 14 affiliations

Find Dr. Malolepszy's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. John Malolepszy is an internist in Braintree, Massachusetts

Dr. Malolepszy practices at Harvard Vanguard Medical Associates in Braintree, Massachusetts.

Dr. Malolepszy's NPI, 1508993163, was assigned on February 28, 2007. Dr. Malolepszy graduated from Geisel School of Medicine at Dartmouth in 1993. Dr. Malolepszy holds Massachusetts license 151408.

NPI and contact details
Medicare PAC ID
6800708058
NPI enumeration date
February 28, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(617) 421-1000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
59
Medical school graduation
1993

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. John Malolepszy practices at Harvard Vanguard Medical Associates in Braintree, Massachusetts

Dr. Malolepszy's primary practice is Harvard Vanguard Medical Associates, at 111 Grossman Dr, Braintree, MA 02184 in Norfolk County. The practice phone is (617) 421-1000.

  • Harvard Vanguard Medical Associates
    111 Grossman Dr, Braintree, MA 02184 · Norfolk CountyPhone(617) 421-1000

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. John Malolepszy is affiliated with 13 sites of care and 1 medical group

Dr. Malolepszy's primary practice is Harvard Vanguard Medical Associates in Braintree, Massachusetts. Dr. Malolepszy is also affiliated with Massachusetts General Hospital. The medical group on file is Atrius Health. Dmand AI also links Dr. Malolepszy to 5 more hospitals, 4 home health agencies, 1 group practice or clinic and 1 hospice, each named with a free account.

See all 14 affiliations for Dr. Malolepszy

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. John Malolepszy's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malolepszy practices, 12 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Harvard Vanguard Medical AssociatesAvailable with a free account
+12 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Malolepszy practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. John Malolepszy is one of 5,528 internists in Massachusetts

Internal medicine is Dr. Malolepszy's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Malolepszy is licensed in Massachusetts.

Specialties and state licenses

  • Internal medicine, MassachusettsPrimaryLicense 151408 · taxonomy 207R00000X

Internists near Dr. Malolepszy

Counts of internists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. John Malolepszy billed Medicare for 4,076 services in 2024

CMS data shows 4,076 Medicare services from Dr. Malolepszy across 43 procedure codes in 2024, for 424 Medicare patients. Medicare paid $90,256 for them. Every service was in an office.

Medicare services, 20244,076
Medicare patients424
Paid by Medicare$90,256
Procedure codes43

Dr. Malolepszy's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Lab and pathology
2023: 2,0192024: 2,1376%
Surgery
2023: 6622024: 6833%
Office and hospital visits
2023: 6052024: 67311%
Other services
2023: 4592024: 4267%
Tests and treatments
2023: 1292024: 15722%

Dr. Malolepszy compared with the Massachusetts median for internists, 2024

  • Dr. Malolepszy
  • Massachusetts median
Medicare services
4,076vs 4319.5 times
Medicare patients
424vs 1942.2 times
Part D claims
6,137vs 40215.3 times

Medians across 5,369 internists in Massachusetts with Dmand AI profiles that report each measure.

Dr. Malolepszy's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Malolepszy

Need commercial claims for Dr. Malolepszy?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Malolepszy and other internists in Massachusetts.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. John Malolepszy treated 424 Medicare patients in 2024, average age 76

CMS counts 424 Medicare patients who saw Dr. Malolepszy in 2024. The largest group is 75 to 84, with 199 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Malolepszy's median patient age at 72, with 31% women.

Medicare patients, 2024424
Average age76
Average risk score1.15
Also on Medicaid9%

Dr. Malolepszy's Medicare patients by age, 2024

Dr. Malolepszy's Medicare patients by sex, 2024

  • Women13532%
  • Men28968%

Chronic conditions among Dr. Malolepszy's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure70%
  3. Arthritis37%
  4. Chronic kidney disease28%
  5. Diabetes26%
  6. Ischemic heart disease26%
  7. Anxiety22%
  8. Atrial fibrillation19%

Share of Medicare patients with each condition. A patient can have several.

Dr. Malolepszy's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women31%
  • Men68%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. John Malolepszy wrote 6,789 Medicare Part D claims in 2024

In 2024, Dr. Malolepszy wrote 6,789 Medicare Part D claims for 588 patients. 91% of them were for generic drugs. CMS names the drug for 6,137 of them, across 102 drugs with 11 or more claims each, at $319,348 in total drug cost. In 2023, CMS named 5,830 claims across 108 drugs.

Part D claims, 20246,789
Drugs named by CMS102
Total drug cost$319,348
Part D patients588

Dr. Malolepszy's Part D claims by kind of drug, 2024

  • Generic6,207 claims91%
  • Brand-name and other582 claims9%

Dr. Malolepszy's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Malolepszy's Part D claims, 2024

  • Opioids3%206 of 6,789 claims
  • Antibiotics2%110 of 6,789 claims
  • Antipsychotics, patients 65 and over0%25 of 6,789 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5,8302024: 6,1375%

Drugs named by CMS: 102 in 2024, 108 in 2023.

See all prescribing by Dr. Malolepszy

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. John Malolepszy offers telehealth to Medicare patients

Dr. Malolepszy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Malolepszy as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find internists like Dr. Malolepszy by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. John Malolepszy received $652 in industry payments from 2017 to 2020

CMS Open Payments shows 6 general payments to Dr. Malolepszy from 1 drug or device company from 2017 to 2020. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $652.

General payments to Dr. Malolepszy by program year, 2017 to 2020

Companies that paid Dr. Malolepszy the most, 2017 to 2020

Share is of all general payments to this clinician.

See all payments to Dr. Malolepszy

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. John Malolepszy graduated from Geisel School of Medicine at Dartmouth

Dr. Malolepszy graduated from Geisel School of Medicine at Dartmouth in 1993.

  1. Medical schoolGeisel School of Medicine at Dartmouth

Source: Dmand AI Professional Profile Data

Sources for Dr. John Malolepszy's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. John Malolepszy

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. John Malolepszy's NPI number?

Dr. John Malolepszy's NPI number is 1508993163. It was assigned on February 28, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. John Malolepszy?

Dr. John Malolepszy is an internist in Braintree, Massachusetts. The primary specialty in the NPI Registry is Internal Medicine Physician (taxonomy code 207R00000X).

Where does Dr. John Malolepszy practice?

Dr. Malolepszy practices at 111 Grossman Dr, Braintree, MA 02184. Dr. Malolepszy's primary practice is Harvard Vanguard Medical Associates in Braintree, Massachusetts. Dmand AI also links Dr. Malolepszy to 5 hospitals, 4 home health agencies, 1 group practice or clinic and 1 hospice.

What is Dr. John Malolepszy's office phone number?

The practice phone on file for Dr. Malolepszy is (617) 421-1000.

What is Dr. John Malolepszy's medical license number?

Dr. Malolepszy holds Massachusetts license 151408.

Which hospitals is Dr. John Malolepszy affiliated with?

Dr. Malolepszy is affiliated with Massachusetts General Hospital. Dmand AI links Dr. Malolepszy to 5 more hospitals.

What medical group is Dr. John Malolepszy part of?

Dr. Malolepszy is linked to Atrius Health.

Does Dr. John Malolepszy accept Medicare?

Yes. CMS data shows Dr. Malolepszy billed Medicare for 4,076 services in 2024, and Dr. Malolepszy accepts Medicare assignment.

Does Dr. John Malolepszy offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Malolepszy as offering telehealth services.

How many Medicare patients does Dr. John Malolepszy see?

CMS counts 424 Medicare patients who saw Dr. Malolepszy in 2024, with an average age of 76.

Show 5 more questionsShow fewer questions

What services does Dr. John Malolepszy bill to Medicare?

In 2024, Dr. Malolepszy's most billed Medicare services were surgery: heart and blood vessels (36415), office visit, established patient (99214) and lab and pathology test (80061).

Where did Dr. John Malolepszy go to medical school?

Dr. Malolepszy graduated from Geisel School of Medicine at Dartmouth in 1993.

What drugs does Dr. John Malolepszy prescribe most?

In 2024 Medicare Part D data, Dr. Malolepszy's most prescribed drugs by claims were Lisinopril, Atorvastatin Calcium and Simvastatin.

Has Dr. John Malolepszy received payments from drug or device companies?

CMS Open Payments shows $652 in general payments to Dr. Malolepszy from 1 company from 2017 to 2020. The largest total came from Pfizer Inc.

How long has Dr. John Malolepszy been practicing?

Dr. Malolepszy graduated from medical school in 1993, 33 years ago.

Selling to internal medicine practices?

See internists in Massachusetts by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)